Purchase Order 75D30119P05329

Award Date 6/28/19
Potential Completion Date 12/16/19
Potential Value $120K
Federal Agency
CDC Pittsburgh
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Potomac, MD 20850, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $49,536,000.00 firm fixed price definitive contract awarded by the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to Maxim Biomedical, Inc., a small disadvantaged, woman-owned, Asian-Pacific American-owned business located in Rockville, Maryland. The contract is for the delivery of over-the-counter (OTC) COVID-19 tests with a period of performance through March 19, 2025. Maxim Biomedical has previously received other...
The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a firm fixed price purchase order to Maxim Biomedical, Inc., a self-certified small disadvantaged, woman-owned, and Asian-Pacific American-owned business, for the development of lateral flow immunoassays (LFIs). The $251,080.00 contract, which has a Coronavirus COVID-19 national interest action code, is for the delivery of LFIs to support COVID-19 testing efforts across the Department of...
The Department of Health and Human Services (HHS) National Institutes of Health National Heart Lung and Blood Institute awarded a $5,253,450.00 firm fixed-price contract to Maxim Biomedical, Inc. to provide RADX TECH SARS-COV-2 antigen rapid tests. The contract has an estimated completion date of August 27, 2023 and was awarded on August 28, 2020. Maxim Biomedical is a small disadvantaged, woman-owned, Asian-Pacific American owned business that specializes in medical device manufacturing,...
This federal contract award was made by the Centers for Disease Control and Prevention (CDC) to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific Inc. The $91,758.84 firm fixed-price purchase order is for the delivery of HIV test kits and supplies. The contract does not have a set-aside designation and has an ultimate completion date of December 31, 2021. Life Technologies Corporation, as the prime contractor, is a leading provider of biomedical research and genetic...
This firm fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh to Luminex Corporation, a manufacturer of biological testing technologies, including multiplex diagnostic solutions. The $66,900.00 contract is for the delivery of various protocols and documentation related to HIV assay, including client data analysis, coupling, bead drying, assay, buffer formulation, reagent handling, and plasma preparation. The contract does not have a set-aside...
The Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh awarded a $75,680 firm fixed price purchase order to Premier Medical USA Corporation of Plainfield, NJ for the delivery of SURESTATUS HIV-1 RECENCY CARD TEST AND FIRST RESPONSE HIV 1-2.O CARD TEST (VERSION 2.0). The tests will help the CDC monitor and track HIV infection rates as part of its efforts to prevent and treat HIV/AIDS. No set-aside designation was used for this award. Premier Medical...
This federal contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Promega Corporation, a global life sciences company that manufactures laboratory equipment and reagents. The $138,722.80 firm fixed price purchase order is for a Maxwell CSC 48 Instrument, which will be used to ensure safe drinking water for research animals and minimize variables during animal studies. The contract represents a sole source award to Promega, as the...
This is a federal purchase order contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to LGC Clinical Diagnostics Inc., a foreign-owned for-profit manufacturer of clinical diagnostic products. The contract, valued at $21,556.49, is for the provision of HIV Performance Panels, which are quality control tools used in clinical laboratories. The contract has a completion date of September 30, 2019 and a firm fixed price pricing type. This...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $89,600.84 firm-fixed-price purchase order to Promega Corporation, doing business as Promega Corp, for the MAXWELL RSC SYSTEM AGREEMENT. This award is not set-aside and has a completion date of August 19, 2027. Promega is a global life sciences company that provides specialized equipment, consumables, and services to federal agencies like the NIH, CDC, DOD, and FBI for a range of biomedical research,...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed price purchase order worth $125,096.60 to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, for HIV-1 control kits. The order has an anticipated completion date of August 25, 2022 and did not utilize any set-aside designations. Abbott Molecular is a manufacturer of molecular diagnostic products and services that has previously supported federal customers such as the Department of...

The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed price purchase order to Maxim Biomedical, Inc., a small disadvantaged, woman-owned, Asian-Pacific American-owned medical device manufacturing company based in Rockville, Maryland. The $120,150.00 award is for the provision of SWIFT HIV RECENT INFECTION ASSAY (RIA) KITS. This sole source contract was issued under the authority of FAR 13.106-1(b) and 10 U.S.C. 2304(c)(1) due to brand name requirements. The original solicitation was posted on May 16, 2019 with a due date of May 27, 2019, and Maxim Biomedical was awarded the contract on June 28, 2019. Maxim Biomedical has previously provided COVID-19 and HIV testing solutions to the HHS, NIH, CDC, and Department of Defense under other prime federal contracts and subrecipient agreements.

Generated 3/23/24, 6:41 AM